Distance as an Obstacle to Clinical Trial Access: Who Is Affected and Why It Matters
Link
Description
Evaluates factors associated with geographic remoteness of 60 miles or more from the nearest phase 2 or 3 clinical trial for a variety of health conditions. Discusses American Indian reservations and rural areas, and provides data on demographic factors associated with remoteness including race and ethnicity, educational attainment, and poverty. Includes a county-level interactive map of clinical trial remoteness for health conditions including cancers, substance use disorder, diabetes, obesity, COPD, stroke, and more. Requires the creation of a free account to view.
Author(s)
Andrew Friedson, Bumyang Kim, Maggie Switek, Lawson Mansell
Date
06/2024
Organization
The Milken Institute
Tagged as
Access
· Arthritis
· COVID-19
· Cancer
· Cardiovascular disease
· Chronic respiratory conditions
· County-by-county data
· Dementia
· Diabetes
· Educational attainment
· HIV and AIDS
· Infectious diseases
· Mental health conditions
· Obesity and weight control
· Poverty
· Rural-urban differences
· Statistics and data
· Substance use and misuse
· Tribal communities